What is the approximate price of one box of Capivasertib?

Capivasertib, in combination with Fulvestrant, is indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic (spread) breast cancer in patients whose disease has progressed after endocrine therapy and who harbor genetic abnormalities (e.g., PIK3CA, AKT1, or PTEN mutations).

What is the approximate price of one box of Capivasertib?

Capivasertib developed by Lucius Pharmaceuticals is currently available in two regular packaging specifications: 160mg × 64 tablets/box and 200mg × 64 tablets/box, to meet the needs of different treatment courses and stages. The specific price of the medicine may fluctuate due to factors such as procurement channels, purchase quantity, packaging standards, and market policies.

For real-time pricing, detailed product information, or purchase consultations, please feel free to contact us via the contact information provided on the homepage. We will provide timely assistance and arrange follow-up matters for you.

How to use Capivasertib?

1. Capivasertib is an oral tablet. It is usually administered twice daily (approximately 12 hours apart), with or without food, during the first 4 days of a 7-day cycle. This cycle may be repeated as advised by the physician. Take Capivasertib at roughly the same times each day (usually morning and evening). Follow the instructions on the prescription label carefully. Consult your doctor or pharmacist if you have any questions. Take Capivasertib exactly as directed. Do not take more or less of it, or take it more often than prescribed by your doctor.

2. Swallow the tablet whole with warm water; do not split, chew, or crush the tablet. Do not take any tablet that is broken, chipped, or damaged in any way.

3. If you vomit after taking a dose, do not take an extra dose. Resume your regular dosing schedule the next day.

4. Your doctor may temporarily or permanently discontinue treatment, or adjust your dose of Capivasertib, based on your response to therapy and any side effects that occur. Communicate with your doctor about how you feel during treatment. Continue taking Capivasertib even if you feel well. Do not stop taking Capivasertib without consulting your doctor.

5. If you have not gone through menopause (cessation of menstruation) or have just entered menopause, your doctor will most likely prescribe another medication (e.g., Goserelin [Zoladex] or Leuprorelin [Eligard, Lupron]) to be used in combination with Capivasertib and Fulvestrant for the treatment of your breast cancer.

What special precautions should be followed?

Before taking Capivasertib:

1. Inform your doctor and pharmacist if you are allergic to Capivasertib, any other medications, or any of the ingredients in Capivasertib tablets. Ask your pharmacist for a list of the ingredients.

2. Inform your doctor and pharmacist about all prescription and over-the-counter medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may need to adjust the doses of your other medications or monitor you closely for side effects.

3. St. John’s Wort may interact with Capivasertib. Be sure to inform your doctor and pharmacist if you are taking this product before starting Capivasertib. Do not start taking St. John’s Wort during treatment with Capivasertib without discussing it with your doctor.

4. Inform your doctor if you have a history of skin rashes or other skin disorders, hypertriglyceridemia (elevated levels of a fatty substance in the blood), or kidney or liver problems.